Lantern Pharma Inc.
LTRN
$4.44
-$0.13-2.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.19% | -48.59% | -41.86% | -37.55% | -30.63% |
| Total Receivables | -- | -- | -88.72% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.94% | -18.25% | -3.51% | -34.30% | -41.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -60.64% | 32.63% | -- | -6.15% | -24.24% |
| Total Current Assets | -51.26% | -47.24% | -41.75% | -36.91% | -30.86% |
|
|
|||||
| Total Current Assets | -51.26% | -47.24% | -41.75% | -36.91% | -30.86% |
| Net Property, Plant & Equipment | -30.57% | -0.55% | 2.50% | 4.97% | -26.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.69% | 41.70% | 41.70% | 41.70% | 23.55% |
| Total Assets | -51.05% | -46.91% | -41.41% | -36.59% | -30.80% |
|
|
|||||
| Total Accounts Payable | 39.24% | 81.46% | 156.36% | 62.42% | 42.58% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.82% | -9.27% | 10.29% | 17.44% | 0.55% |
| Total Finance Division Other Current Liabilities | -31.45% | -44.57% | 10.36% | 65.70% | 74.55% |
| Total Other Current Liabilities | -31.45% | -44.57% | 10.36% | 65.70% | 74.55% |
| Total Current Liabilities | 6.16% | 8.42% | 61.72% | 59.81% | 52.55% |
|
|
|||||
| Total Current Liabilities | 6.16% | 8.42% | 61.72% | 59.81% | 52.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -75.32% | 114.10% | -14.15% | -11.74% | -63.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.21% | 8.84% | 60.02% | 56.58% | 47.01% |
|
|
|||||
| Common Stock & APIC | 0.81% | 0.79% | 0.83% | 0.17% | 0.17% |
| Retained Earnings | -29.32% | -32.75% | -37.62% | -37.39% | -37.05% |
| Treasury Stock & Other | 827.27% | 6,831.58% | 243.26% | 81.77% | 97.48% |
| Total Common Equity | -59.52% | -53.09% | -48.21% | -41.43% | -35.91% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -59.52% | -53.09% | -48.21% | -41.43% | -35.91% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -59.52% | -53.09% | -48.21% | -41.43% | -35.91% |
|
|
|||||